Phospho-PRC1 (Thr470) Antibody - #AF8393
製品: | Phospho-PRC1 (Thr470) Antibody |
カタログ: | AF8393 |
タンパク質の説明: | Rabbit polyclonal antibody to Phospho-PRC1 (Thr470) |
アプリケーション: | WB IHC |
反応性: | Human, Mouse |
予測: | Pig, Horse, Sheep |
分子量: | 72kDa; 72kD(Calculated). |
ユニプロット: | O43663 |
RRID: | AB_2840454 |
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF8393, RRID:AB_2840454.
折りたたみ/展開
Anaphase spindle elongation 1 homolog; ASE1; PRC1; PRC1_HUMAN; Protein regulating cytokinesis 1; Protein regulator of cytokinesis 1;
免疫原
- O43663 PRC1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MRRSEVLAEESIVCLQKALNHLREIWELIGIPEDQRLQRTEVVKKHIKELLDMMIAEEESLKERLIKSISVCQKELNTLCSELHVEPFQEEGETTILQLEKDLRTQVELMRKQKKERKQELKLLQEQDQELCEILCMPHYDIDSASVPSLEELNQFRQHVTTLRETKASRREEFVSIKRQIILCMEALDHTPDTSFERDVVCEDEDAFCLSLENIATLQKLLRQLEMQKSQNEAVCEGLRTQIRELWDRLQIPEEEREAVATIMSGSKAKVRKALQLEVDRLEELKMQNMKKVIEAIRVELVQYWDQCFYSQEQRQAFAPFCAEDYTESLLQLHDAEIVRLKNYYEVHKELFEGVQKWEETWRLFLEFERKASDPNRFTNRGGNLLKEEKQRAKLQKMLPKLEEELKARIELWEQEHSKAFMVNGQKFMEYVAEQWEMHRLEKERAKQERQLKNKKQTETEMLYGSAPRTPSKRRGLAPNTPGKARKLNTTTMSNATANSSIRPIFGGTVYHSPVSRLPPSGSKPVAASTCSGKKTPRTGRHGANKENLELNGSILSGGYPGSAPLQRNFSINSVASTYSEFAKDPSLSDSSTVGLQRELSKASKSDATSGILNSTNIQS
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - O43663 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S4 | Phosphorylation | Uniprot | |
K17 | Ubiquitination | Uniprot | |
K67 | Ubiquitination | Uniprot | |
S70 | Phosphorylation | Uniprot | |
K74 | Ubiquitination | Uniprot | |
K101 | Ubiquitination | Uniprot | |
T105 | Phosphorylation | Uniprot | |
R111 | Methylation | Uniprot | |
K178 | Ubiquitination | Uniprot | |
S195 | Phosphorylation | Uniprot | |
K229 | Ubiquitination | Uniprot | |
R249 | Methylation | Uniprot | |
T262 | Phosphorylation | Uniprot | |
S265 | Phosphorylation | Uniprot | |
S267 | Phosphorylation | Uniprot | |
K268 | Ubiquitination | Uniprot | |
K273 | Ubiquitination | Uniprot | |
R281 | Methylation | Uniprot | |
K286 | Ubiquitination | Uniprot | |
K349 | Ubiquitination | Uniprot | |
T379 | Phosphorylation | Uniprot | |
K387 | Sumoylation | Uniprot | |
K387 | Ubiquitination | Uniprot | |
K390 | Ubiquitination | Uniprot | |
K401 | Sumoylation | Uniprot | |
K401 | Ubiquitination | Uniprot | |
K419 | Ubiquitination | Uniprot | |
K453 | Acetylation | Uniprot | |
K456 | Ubiquitination | Uniprot | |
Y464 | Phosphorylation | Uniprot | |
S466 | Phosphorylation | Uniprot | |
T470 | Phosphorylation | Uniprot | |
S472 | Phosphorylation | Uniprot | |
R475 | Methylation | Uniprot | |
T481 | Phosphorylation | P06493 (CDK1) | Uniprot |
K484 | Ubiquitination | Uniprot | |
K487 | Ubiquitination | Uniprot | |
T509 | Phosphorylation | Uniprot | |
Y511 | Phosphorylation | Uniprot | |
S513 | Phosphorylation | Uniprot | |
S516 | Phosphorylation | Uniprot | |
S521 | Phosphorylation | Uniprot | |
S523 | Phosphorylation | Uniprot | |
K524 | Ubiquitination | Uniprot | |
S529 | Phosphorylation | Uniprot | |
T530 | Phosphorylation | Uniprot | |
S532 | Phosphorylation | Uniprot | |
K534 | Acetylation | Uniprot | |
T536 | Phosphorylation | Uniprot | |
S554 | Phosphorylation | Uniprot | |
S557 | Phosphorylation | Uniprot | |
Y560 | Phosphorylation | Uniprot | |
S563 | Phosphorylation | Uniprot | |
S571 | Phosphorylation | Uniprot | |
S574 | Phosphorylation | Uniprot | |
S577 | Phosphorylation | Uniprot | |
T578 | Phosphorylation | Uniprot | |
S587 | Phosphorylation | Uniprot | |
S589 | Phosphorylation | Uniprot | |
S591 | Phosphorylation | Uniprot | |
S592 | Phosphorylation | Uniprot | |
T593 | Phosphorylation | Uniprot | |
K602 | Ubiquitination | Uniprot | |
K605 | Ubiquitination | Uniprot | |
S615 | Phosphorylation | P53350 (PLK1) | Uniprot |
T616 | Phosphorylation | P53350 (PLK1) | Uniprot |
S620 | Phosphorylation | Uniprot |
研究背景
Key regulator of cytokinesis that cross-links antiparrallel microtubules at an average distance of 35 nM. Essential for controlling the spatiotemporal formation of the midzone and successful cytokinesis. Required for KIF14 localization to the central spindle and midbody. Required to recruit PLK1 to the spindle. Stimulates PLK1 phosphorylation of RACGAP1 to allow recruitment of ECT2 to the central spindle. Acts as an oncogene for promoting bladder cancer cells proliferation, apoptosis inhibition and carcinogenic progression.
Phosphorylation by CDK1 in early mitosis holds PRC1 in an inactive monomeric state, during the metaphase to anaphase transition, PRC1 is dephosphorylated, promoting interaction with KIF4A, which then translocates PRC1 along mitotic spindles to the plus ends of antiparallel interdigitating microtubules. Dephosphorylation also promotes MT-bundling activity by allowing dimerization. Phosphorylation by CDK1 prevents PLK1-binding: upon degradation of CDK1 at anaphase and dephosphorylation, it is then phosphorylated by PLK1, leading to cytokinesis.
Nucleus. Cytoplasm. Cytoplasm>Cytoskeleton>Spindle pole. Midbody.
Note: Colocalized with KIF20B in the nucleus of bladder carcinoma cells at the interphase. Colocalized with KIF20B in bladder carcinoma cells at prophase, metaphase, early anaphase, at the midzone in late anaphase and at the contractile ring in telophase (PubMed:17409436). Predominantly localized to the nucleus of interphase cells. During mitosis becomes associated with the mitotic spindle poles and localizes with the cell midbody during cytokinesis.
Overexpressed in bladder cancer cells.
Homodimer. Interacts with the C-terminal Rho-GAP domain and the basic region of RACGAP1. The interaction with RACGAP1 inhibits its GAP activity towards CDC42 in vitro, which may be required for maintaining normal spindle morphology. Interacts separately via its N-terminal region with the C-terminus of CENPE, KIF4A and KIF23 during late mitosis. Interacts with KIF14 and KIF20A. Interacts with PLK1. Interacts with KIF20B.
Microtubule binding occurs via a basic patch in the central spectrin-like domain and requires also the unstructured C-terminal domain.
Belongs to the MAP65/ASE1 family.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.